Radiotherapy Market Size 2021, Industry Statistics, Business Models, Technology Development Trends, Top Companies, Forecast to 2025
Research Reports
Dec 28, 2020
Radiotherapy or radiation therapy is a treatment designed to reduce the size of tumors, blood disorders, and thyroid disease. It is highly recommended by doctors due to being a part of targeted therapy. Targeted therapies can assist doctors in targeting specific areas of the human body while reducing the damage to other body organs. The global radiotherapy market report by Market Research Future (MRFR) contains useful insights deemed to assist market players in their strategies for the period between 2019 to 2025 (forecast period).
Radiotherapy Market Outlook
The global radiotherapy market size is expected to showcase a CAGR of 4.7% during the forecast period due to high prevalence of cancer cases. As per the statistics by the American Cancer Society, nearly 1.9 million cases are expected to occur in 2019. The preference of radiotherapy as a line of treatment for reducing and eliminating malignant tumors can drive the market growth. Technological advances in radiation therapy as well as continuous clinical trials for testing new drugs to reduce the effects of the treatment can bode well for the market.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/1526
Adoption of radiotherapy for the treatment of various cancers as well as procurement of latest devices and drugs for palliative care of cancer patients can spur the market demand till 2025. Government investments in research of radiotherapy can facilitate market growth.
However, low access as well as unavailability of treatments at affordable prices can hamper market growth.
Radiotherapy Market Segmentation
The global radiotherapy market has been segmented based on type, application, end user, and region.
The global radiotherapy market, based on type, has been segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. External radiation therapy is further divided into stereotactic body radiation therapy, image guided radiation therapy, intensity modulated radiation therapy, tomotherapy, stereotactic radio surgery, and proton therapy. On the basis of the type segment, the external beam radiation therapy segment is expected to hold a major share in the market due to the reduced risk of radiation exposure during the treatment and the increased precision and accuracy of tumor targeting.
The global radiotherapy market, based on application, has been segmented into skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer, and others.
The global radiotherapy market, based on equipment, has been segmented into linear accelerators, radiation therapy simulators, and treatment planning systems.
The global radiotherapy market, based on end use, has been segmented into hospitals and independent radiotherapy centers.
Radiotherapy Market Regional Analysis
Based on region, the radiotherapy market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas is expected to dominate the global radiotherapy market due to novel treatment discovered in targeted therapy and the rise in per capita expenditure in healthcare. High number of cancer cases in the U.S. and Canada are likely to drive the regional market growth.
Radiotherapy Market Competitive Landscape
Elekta AB (pub), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., IBA (Ion Beam Applications Sa), Hitachi, Ltd., P-Cure Ltd., Isoray Medical, Inc., Panacea Medical Technologies Pvt. Ltd., Elekta, Varian Medical Systems, Inc., Provision Healthcare, LLC, and C. R. Bard, Inc., are key players of the global radiotherapy market. Companies are focusing on mergers, acquisitions, and collaborations to gain leverage over the competition.
Radiotherapy Industry Update
Galera Therapeutics recently published the results of a clinical trial for its latest drug, avasopasem manganese (GC4419). The added dose of GC4419 to the radiotherapy treatment has reduced the duration of severe oral mucositis (SOM) to 1.5 days from the original 19 days. This can revolutionize the global radiotherapy market and influence market solution providers to improve their treatment procedures.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/radiotherapy-market-1526
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English